Clinical trials for Cancer in United States

A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)

Study ID: NCT06833073

Sponsor

Merck Sharp & Dohme LLC

Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss

Study ID: NCT05484973

Sponsor

Cooler Heads Care Inc.

A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma

Study ID: NCT06594991

Sponsor

Memorial Sloan Kettering Cancer Center

CER-1236 in Patients With Acute Myeloid Leukemia (AML)

Study ID: NCT06834282

Sponsor

CERo Therapeutics Holdings, Inc.

Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

Study ID: NCT06625320

Sponsor

Revolution Medicines, Inc.

A Study of NX-1607 in Adults With Advanced Malignancies

Study ID: NCT05107674

Sponsor

Nurix Therapeutics, Inc.

CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer

Study ID: NCT05187182

Sponsor

Washington University School of Medicine

An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

Study ID: NCT01668082

Sponsor

University of Texas Southwestern Medical Center

Utilization of Educational Interventions in Completion of Genetic Testing in Black Patients with High-Risk Prostate Cancer

Study ID: NCT05958082

Sponsor

Henry Ford Health System

Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study

Study ID: NCT05361720

Sponsor

Vanderbilt-Ingram Cancer Center